Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial

AIMS: The randomized, controlled EAST-AFNET 4 trial showed that early rhythm control (ERC) reduces the rate of a composite primary outcome (cardiovascular death, stroke, or hospitalization for worsening heart failure or acute coronary syndrome) by ∼20%. The current study examined the cost-effectiven...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottschalk, Sophie, Kany, Shinwan, König, Hans-Helmut, Crijns, Harry JGM, Vardas, Panos, Camm, A John, Wegscheider, Karl, Metzner, Andreas, Rillig, Andreas, Kirchhof, Paulus, Dams, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227663/
https://www.ncbi.nlm.nih.gov/pubmed/36966734
http://dx.doi.org/10.1093/europace/euad051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227663/
https://www.ncbi.nlm.nih.gov/pubmed/36966734
http://dx.doi.org/10.1093/europace/euad051

Ejemplares similares